Intergenerational Effects of Sevoflurane in Young Adult Rats.
Journal
Anesthesiology
ISSN: 1528-1175
Titre abrégé: Anesthesiology
Pays: United States
ID NLM: 1300217
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
pubmed:
14
9
2019
medline:
31
3
2020
entrez:
14
9
2019
Statut:
ppublish
Résumé
Sevoflurane administered to neonatal rats induces neurobehavioral abnormalities and epigenetic reprogramming of their germ cells; the latter can pass adverse effects of sevoflurane to future offspring. As germ cells are susceptible to reprogramming by environmental factors across the lifespan, the authors hypothesized that sevoflurane administered to adult rats could induce neurobehavioral abnormalities in future offspring, but not in the exposed rats themselves. Sprague-Dawley rats were anesthetized with 2.1% sevoflurane for 3 h every other day between postnatal days 56 and 60. Twenty-five days later, exposed rats and nonexposed controls were mated to produce offspring. Adult male but not female offspring of exposed parents of either sex exhibited deficiencies in elevated plus maze (mean ± SD, offspring of both exposed parents vs. offspring of control parents, 35 ± 12 vs. 15 ± 15 s, P < 0.001) and prepulse inhibition of acoustic startle (offspring of both exposed parents vs. offspring of control parents, 46.504 ± 13.448 vs. 25.838 ± 22.866%, P = 0.009), and increased methylation and reduced expression of the potassium ion-chloride ion cotransporter KCC2 gene (Kcc2) in the hypothalamus. Kcc2 was also hypermethylated in sperm and ovary of the exposed rats. Surprisingly, exposed male rats also exhibited long-term abnormalities in functioning of the hypothalamic-pituitary-gonadal and -adrenal axes, reduced expression of hypothalamic and hippocampal Kcc2, and deficiencies in elevated plus maze (sevoflurane vs. control, 40 ± 24 vs. 25 ± 12 s, P = 0.038) and prepulse inhibition of startle (sevoflurane vs. control, 39.905 ± 21.507 vs. 29.193 ± 24.263%, P < 0.050). Adult sevoflurane exposure affects brain development in male offspring by epigenetically reprogramming both parental germ cells, while it induces neuroendocrine and behavioral abnormalities only in exposed males. Sex steroids may be required for mediation of the adverse effects of adult sevoflurane in exposed males.
Sections du résumé
BACKGROUND
Sevoflurane administered to neonatal rats induces neurobehavioral abnormalities and epigenetic reprogramming of their germ cells; the latter can pass adverse effects of sevoflurane to future offspring. As germ cells are susceptible to reprogramming by environmental factors across the lifespan, the authors hypothesized that sevoflurane administered to adult rats could induce neurobehavioral abnormalities in future offspring, but not in the exposed rats themselves.
METHODS
Sprague-Dawley rats were anesthetized with 2.1% sevoflurane for 3 h every other day between postnatal days 56 and 60. Twenty-five days later, exposed rats and nonexposed controls were mated to produce offspring.
RESULTS
Adult male but not female offspring of exposed parents of either sex exhibited deficiencies in elevated plus maze (mean ± SD, offspring of both exposed parents vs. offspring of control parents, 35 ± 12 vs. 15 ± 15 s, P < 0.001) and prepulse inhibition of acoustic startle (offspring of both exposed parents vs. offspring of control parents, 46.504 ± 13.448 vs. 25.838 ± 22.866%, P = 0.009), and increased methylation and reduced expression of the potassium ion-chloride ion cotransporter KCC2 gene (Kcc2) in the hypothalamus. Kcc2 was also hypermethylated in sperm and ovary of the exposed rats. Surprisingly, exposed male rats also exhibited long-term abnormalities in functioning of the hypothalamic-pituitary-gonadal and -adrenal axes, reduced expression of hypothalamic and hippocampal Kcc2, and deficiencies in elevated plus maze (sevoflurane vs. control, 40 ± 24 vs. 25 ± 12 s, P = 0.038) and prepulse inhibition of startle (sevoflurane vs. control, 39.905 ± 21.507 vs. 29.193 ± 24.263%, P < 0.050).
CONCLUSIONS
Adult sevoflurane exposure affects brain development in male offspring by epigenetically reprogramming both parental germ cells, while it induces neuroendocrine and behavioral abnormalities only in exposed males. Sex steroids may be required for mediation of the adverse effects of adult sevoflurane in exposed males.
Identifiants
pubmed: 31517640
doi: 10.1097/ALN.0000000000002920
pmc: PMC6801066
mid: NIHMS1534629
doi:
Substances chimiques
Anesthetics, Inhalation
0
Sevoflurane
38LVP0K73A
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1092-1109Subventions
Organisme : NINDS NIH HHS
ID : R01 NS091542
Pays : United States
Références
Neuroscience. 2009 Mar 17;159(2):883-95
pubmed: 19166915
J Comp Physiol B. 2010 Aug;180(6):785-96
pubmed: 20544204
Anesthesiology. 2009 Apr;110(4):834-48
pubmed: 19293705
Nat Neurosci. 2009 Apr;12(4):438-43
pubmed: 19252497
J Theor Biol. 1994 Aug 7;169(3):313-5
pubmed: 7967623
Curr Opin Anaesthesiol. 2016 Aug;29(4):447-53
pubmed: 27168087
Eur J Neurosci. 2012 Jun;35(12):1846-56
pubmed: 22708595
Saudi J Anaesth. 2015 Apr-Jun;9(2):184-8
pubmed: 25829908
J Psychiatr Res. 2011 Mar;45(3):285-94
pubmed: 20801463
Mol Endocrinol. 2002 Dec;16(12):2872-91
pubmed: 12456806
Psychoneuroendocrinology. 2015 Oct;60:173-81
pubmed: 26150359
Indian J Anaesth. 2016 Mar;60(3):224
pubmed: 27053793
Endocrinology. 2011 Apr;152(4):1541-50
pubmed: 21325051
Nat Rev Neurosci. 2016 Oct 18;17(11):705-717
pubmed: 27752068
J Steroid Biochem Mol Biol. 2016 Jun;160:196-203
pubmed: 26690789
Neurobiol Dis. 2016 Jul;91:209-220
pubmed: 27001149
Indian J Anaesth. 2015 Nov;59(11):706-14
pubmed: 26755835
Brain Res Bull. 2013 Apr;93:69-79
pubmed: 22925739
Environ Epigenet. 2018 Apr 26;4(2):dvy001
pubmed: 29732167
Anesth Analg. 1984 Aug;63(8):729-30
pubmed: 6465557
Br Med J. 1973 Mar 17;1(5854):675
pubmed: 4692717
Neuroscience. 2014 Oct 24;279:187-219
pubmed: 25168736
Am J Physiol Endocrinol Metab. 2007 Apr;292(4):E1173-82
pubmed: 17179393
Biol Psychiatry. 2019 Jan 15;85(2):164-171
pubmed: 30580777
Anesth Analg. 2005 Nov;101(5):1389-92
pubmed: 16243999
Transl Psychiatry. 2017 Mar 14;7(3):e1056
pubmed: 28291262
Environ Res. 2006 Jan;100(1):77-85
pubmed: 15922323
J Neuroendocrinol. 2011 Jul;23(7):557-69
pubmed: 21518033
Physiol Behav. 1994 Jan;55(1):117-24
pubmed: 8140154
Data Brief. 2016 Jan 07;6:521-5
pubmed: 26904715
Psychoneuroendocrinology. 2009 Feb;34(2):226-37
pubmed: 18849120
Neuroendocrinology. 2016;103(5):440-51
pubmed: 26159049
Epigenomics. 2018 Jun;10(6):845-858
pubmed: 29888951
Neurotox Res. 2016 Feb;29(2):243-55
pubmed: 26678494
Nat Neurosci. 2015 May;18(5):690-7
pubmed: 25821913
Am J Psychiatry. 2014 Aug;171(8):872-880
pubmed: 24832930
Anesthesiology. 2016 Jun;124(6):1311-1327
pubmed: 27028464
Anesth Analg. 2011 Nov;113(5):1170-9
pubmed: 21965351
J Anaesthesiol Clin Pharmacol. 2013 Apr;29(2):221-7
pubmed: 23878446
Int J Dev Neurosci. 1998 Jun-Jul;16(3-4):289-95
pubmed: 9785125
Neuron. 2016 Oct 19;92(2):493-504
pubmed: 27720487
J Cereb Blood Flow Metab. 2010 May;30(5):1017-30
pubmed: 20068576
Indian J Anaesth. 2016 Mar;60(3):225
pubmed: 27053794
Exp Neurol. 2003 Dec;184(2):1003-9
pubmed: 14769394
Epigenetics. 2018;13(12):1208-1221
pubmed: 30521419
Psychoneuroendocrinology. 2017 Jul;81:96-104
pubmed: 28433802
Brain Res. 2010 Jun 8;1336:78-88
pubmed: 20381466
Br J Anaesth. 2018 Aug;121(2):406-416
pubmed: 30032879
CNS Neurosci Ther. 2015 Feb;21(2):83-91
pubmed: 25438879
Eur Rev Med Pharmacol Sci. 2018 Mar;22(6):1825-1829
pubmed: 29630132
J Neurosci. 2013 May 22;33(21):9003-12
pubmed: 23699511
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):751-6
pubmed: 26733678